FDA orphan drug designation: treatment of epidermolysis bullosa
All entries for: Eliksa Therapeutics Inc.
September 12, 2025
Eliksa Therapeutics Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of epidermolysis bullosa
